FDA and EMA agree to review shorter infusion time of Roche's Ocrevus.
They are trying to get approval to reduce Ocrelizumab infusion times from 3.5 hours to 2 hours.
https://www.pharmaceutical-technolog...eview-ocrevus/
They are trying to get approval to reduce Ocrelizumab infusion times from 3.5 hours to 2 hours.
https://www.pharmaceutical-technolog...eview-ocrevus/
Comment